4,676 results match your criteria Tricuspid Stenosis

The Evolving Epidemiology of Elderly with Degenerative Valvular Heart Disease: The Guangzhou (China) Heart Study.

Biomed Res Int 2021 23;2021:9982569. Epub 2021 Apr 23.

Department of Cardiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, No. 96 of Dongchuan Road, Guangzhou City, 510080 Guangdong Province, China.

Aim: The present study was aimed at investigating the prevalence, incidence, progression, and prognosis of degenerative valvular heart disease (DVHD) in permanent residents aged ≥65 years from Guangzhou, China.

Methods: This was a prospective study based on community population. Over a 3-year span, we conducted repeated questionnaires, blood tests, and echocardiographic and electrocardiogram examinations (2018) of a random sample of initially 3538 subjects. Read More

View Article and Full-Text PDF

[Suspected Takotsubo Cardiomyopathy after Elective Mitral Valve Replacement:Report of a Case].

Kyobu Geka 2021 May;74(5):358-361

Department of Cardiovascular Surgery, Hamamatsu Rosai Hospital, Hamamatsu, Japan.

Reports of takotsubo cardiomyopathy following cardiac surgery are rare. We report a case of postoperative takotsubo cardiomyopathy after mitral valve replacement (MVR). The patient was a 70-yearold woman with mitral stenosis, regurgitation, and a medical history of long-standing persistent atrial fibrillation. Read More

View Article and Full-Text PDF

Genetic and Developmental Contributors to Aortic Stenosis.

Circ Res 2021 Apr 29;128(9):1330-1343. Epub 2021 Apr 29.

The Herma Heart Institute, Section of Pediatric Cardiology, Children's Wisconsin, Milwaukee, WI (P.D., J.F.J., H.K., J.L.).

Aortic stenosis (AS) remains one of the most common forms of valve disease, with significant impact on patient survival. The disease is characterized by left ventricular outflow obstruction and encompasses a series of stenotic lesions starting from the left ventricular outflow tract to the descending aorta. Obstructions may be subvalvar, valvar, or supravalvar and can be present at birth (congenital) or acquired later in life. Read More

View Article and Full-Text PDF

Impact of tricuspid regurgitation severity and repair on aortic valve replacement.

Ann Thorac Surg 2021 Apr 25. Epub 2021 Apr 25.

Department of Preventive Medicine. Hospital Universitario de La Princesa, Madrid, Spain.

Background: Aortic stenosis is one of the most prevalent valve diseases but is rarely accompanied by tricuspid regurgitation. Our objective was to analyse the impact of tricuspid regurgitation severity and its surgical treatment on prognosis of patients undergoing aortic valve replacement.

Methods: Retrospective cohort study including all patients presenting with aortic stenosis with some degree of tricuspid regurgitation between 2001 and 2018. Read More

View Article and Full-Text PDF

Surgical Treatment of Lutembacher Syndrome with a Huge Right Atrium: A Case Report.

Heart Surg Forum 2021 Apr 7;24(2):E359-E362. Epub 2021 Apr 7.

Department of Cardiovascular Surgery, Yan'an Affiliated Hospital of Kunming Medical University, Kunming, China.

Background: Lutembacher's syndrome (LS) is a rare cardiovascular anomaly that is defined as any combination of congenital or iatrogenic atrial septal defect (ASD) with congenital or acquired mitral stenosis (MS). The clinical features and hemodynamic effects of LS depend on the balance between ASD and MS.

Case Report: In this case report, we describe a rare case of LS with a huge right atrium in a 39-year-old male patient who was admitted to the hospital with worsening fatigue and breathlessness on exertion. Read More

View Article and Full-Text PDF

Double-root inversion for complex malposition of the great arteries with tricuspid valve straddling.

Multimed Man Cardiothorac Surg 2021 03 8;2021. Epub 2021 Mar 8.

University Hospital of Geneva University Hospital of Laussane Switzerland.

Dextro-transposition of the great vessels associated with pulmonary stenosis, double-outlet right ventricle, and straddling of the tricuspid valve is an uncommon condition. Several treatment options are available for this malformation, but most of them are not optimal. For patients with transposition of the great vessels, the gold standard procedure, which is an arterial switch procedure, would usually be performed, whereas for patients with pulmonary stenosis, a Rastelli operation or a Nikaidoh procedure would be proposed. Read More

View Article and Full-Text PDF

Staging cardiac damage associated with aortic stenosis in patients undergoing transcatheter aortic valve implantation.

Int J Cardiol Heart Vasc 2021 Apr 1;33:100768. Epub 2021 Apr 1.

Department of Cardiology, Inselspital, University of Bern, CH-3010 Bern, Switzerland.

Background: A new staging classification of aortic stenosis (AS) characterizing the extent of cardiac damage was established and validated in patients undergoing transcatheter aortic valve implantation (TAVI). The present study was aimed to refine the staging system by integrating a quantitative evaluation of right ventricular (RV) dysfunction defined by current echocardiographic guideline recommendations.

Methods And Results: In a prospective TAVI registry, patients were categorized into the stages: no cardiac damage (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or RV damage (Stage 4) based on baseline echocardiography. Read More

View Article and Full-Text PDF

Predictors of calcification distribution in severe tricuspid aortic valve stenosis.

Int J Cardiovasc Imaging 2021 Apr 20. Epub 2021 Apr 20.

Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.

We investigated aortic valve calcification (AVC) distribution and predictors for leaflet calcification patterns in patients with severe tricuspid aortic valve stenosis undergoing transcatheter aortic valve replacement (TAVR). Patients undergoing routine multi-sliced computed tomography (MSCT) for procedural planning were enrolled. MSCT data were transferred to a dedicated workstation for evaluation (3mensio Structural Heart™, Pie Medical Imaging BV, Maastricht, The Netherlands) and analyzed. Read More

View Article and Full-Text PDF

Early and mid-term results of transcatheter aortic valve implantation and valve durability assessment.

Heart Vessels 2021 Apr 19. Epub 2021 Apr 19.

Department of Cardiovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Saitama, Hidaka, 350-1298, Japan.

This study aimed to evaluate the early and mid-term outcomes of transcatheter aortic valve implantation (TAVI) and to assess valve durability. A total of 146 consecutive patients who underwent TAVI for severe aortic stenosis between October 2013 and August 2018 were retrospectively reviewed. All patients (mean age, 84 ± 6 years; age range 53-98 years; 42 males [28. Read More

View Article and Full-Text PDF

Comparison of the results of transcatheter aortic valve implantation in patients with bicuspid and tricuspid aortic valve.

Postepy Kardiol Interwencyjnej 2021 Mar 27;17(1):82-92. Epub 2021 Mar 27.

Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland.

Introduction: Indications for transcatheter aortic valve implantation (TAVI) are constantly expanding, including younger patients. Bicuspid aortic valves (BAV) often occur in this group. In order to achieve optimal treatment results in younger patients, it is necessary to develop an effective method for selecting the size of implanted valves. Read More

View Article and Full-Text PDF

Aortic Stenosis in Bicuspid and Tricuspid Valves: A Different Spectrum of the Disease With Clinical Implications.

JACC Cardiovasc Imaging 2021 Apr 8. Epub 2021 Apr 8.

Cardiology Department, Hospital Universitari Vall d´Hebron (VHIR), CIBER-CV and Heart Institute Quirón-Teknon, Barcelona, Spain. Electronic address:

View Article and Full-Text PDF

Repair technique for a rare partial anomalous pulmonary venous return associated with retroaortic innominate vein.

J Cardiothorac Surg 2021 Apr 15;16(1):83. Epub 2021 Apr 15.

Department of Thoracic and Cardiovascular Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, 41944, 130 Dongdeok-ro, Jung-gu, Daegu, Republic of Korea.

Background: Retroaortic innominate vein (RIV) is a rare vascular abnormality. Although RIV itself is asymptomatic, its presence in patients with partial anomalous pulmonary venous return (PAPVR) to the superior vena cava (SVC) is surgically challenging because a simple Warden procedure is impossible.

Case Presentation: A 16-year-old girl was diagnosed with tetralogy of Fallot, secundum, and sinus venosus atrial septal defect (ASD) at birth. Read More

View Article and Full-Text PDF

Early onset bioprosthetic tricuspid valve stenosis in a case with cardiac sarcoidosis: Pathological findings based on autopsy.

J Cardiol Cases 2021 Apr 8;23(4):173-176. Epub 2021 Feb 8.

Division of Cardiovascular Surgery, Okinawa Chubu Hospital, Uruma, Okinawa, Japan.

A 60-year-old woman with cardiac sarcoidosis developed recurrent and refractory right heart failure 26 months after tricuspid valve replacement. Echocardiography revealed thickened and immobile cusp with increased diastolic tricuspid gradient of 8-10 mmHg, consistent with bioprosthetic tricuspid stenosis (TS). Prolonged intravenous injection of dobutamine and carperitide, with intermittent intravenous furosemide, was necessary at multiple times. Read More

View Article and Full-Text PDF

Proximal aortic aneurysms: correlation of maximum aortic diameter and aortic wall thickness.

Eur J Cardiothorac Surg 2021 Apr 5. Epub 2021 Apr 5.

University Department for Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.

Objectives: The goal of therapy of proximal aortic aneurysms is to prevent an aortic catastrophe, e.g. acute dissection or rupture. Read More

View Article and Full-Text PDF

Smith-Magenis syndrome: Report of morphological and new functional cardiac findings with review of the literature.

Am J Med Genet A 2021 Apr 3. Epub 2021 Apr 3.

Rare Diseases Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy.

Smith-Magenis syndrome (SMS) is a genetic disorder characterized by multiple congenital anomalies, sleep disturbance, behavioral impairment, and intellectual disability. Its genetic cause has been defined as an alteration in the Retinoic Acid-Induced 1 gene. Cardiac anomalies have been reported since the first description of this condition in patients with 17p11. Read More

View Article and Full-Text PDF

Unusual Presentation of Aortic Valve Infective Endocarditis in a Dog: Aorto-Cavitary Fistula, Tricuspid Valve Endocarditis, and Third-Degree Atrioventricular Block.

Animals (Basel) 2021 Mar 4;11(3). Epub 2021 Mar 4.

Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, 40064 Bologna, Italy.

A 2-year-old Boxer with a history of subaortic stenosis and immunosuppressant therapy developed aortic valve infective endocarditis. On echocardiographic examination with simultaneous electrocardiographic tracing, multiple uncommon periannular complications of the aortic valve endocarditis were found, including aorto-cavitary fistula with diastolic left-to-right shunt, tricuspid valve endocarditis, and third-degree atrioventricular block. Necropsy confirmed the above echocardiographic findings. Read More

View Article and Full-Text PDF

Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction.

Wien Klin Wochenschr 2021 Mar 31. Epub 2021 Mar 31.

Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Valve degeneration after surgical tricuspid valve replacement or repair is frequent and may require repeat replacement/repair. For high-risk patients, transcatheter valve-in-valve and valve-in-ring procedures have emerged as valuable treatment alternatives. Preprocedural transthoracic echocardiography is the method of choice to detect malfunction of the prosthesis including degenerative stenosis and/or regurgitation requiring reintervention. Read More

View Article and Full-Text PDF

Detection and localization of S and S heart sounds by 3rd order normalized average Shannon energy envelope algorithm.

Proc Inst Mech Eng H 2021 Mar 30:954411921998108. Epub 2021 Mar 30.

Department of Instrumentation & Control Engineering, Dr. B. R. Ambedkar National Institute of Technology, Jalandhar, Punjab, India.

Adults born after 1970s are more prone to cardiovascular diseases. Death rate percentage is quite high due to heart related diseases. Therefore, there is necessity to enquire the problem or detection of heart diseases earlier for their proper treatment. Read More

View Article and Full-Text PDF

Frailty in patients undergoing transcatheter aortic valve replacement: prognostic value of the Geriatric Nutritional Risk Index.

J Cachexia Sarcopenia Muscle 2021 Mar 25. Epub 2021 Mar 25.

Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, University Hospital Schleswig-Holstein Kiel, Kiel, Germany.

Background: Malnutrition is a hallmark of frailty, is common among elderly patients, and is a predictor of poor outcomes in patients with severe symptomatic aortic stenosis (AS). The Geriatric Nutritional Risk Index (GNRI) is a simple and well-established screening tool to predict the risk of morbidity and mortality in elderly patients. In this study, we evaluated whether GNRI may be used in the risk stratification and management of patients undergoing transcatheter aortic valve replacement (TAVR). Read More

View Article and Full-Text PDF

Endoscopic Robotic Retrieval of a Migrated Subclavian Vein Stent from the Right Ventricle.

Innovations (Phila) 2021 Mar-Apr;16(2):201-203. Epub 2021 Mar 23.

13713773422646 Department of Surgery, Division of Cardiothoracic Surgery, Emory Saint Joseph's Hospital, Emory University School of Medicine, Atlanta, GA, USA.

A 54-year-old woman with end-stage renal disease on hemodialysis with access through a right arm arteriovenous fistula presented with right arm swelling. Venography demonstrated right subclavian vein stenosis. A balloon angioplasty of the stenotic vein was unsuccessful, and she subsequently underwent stent placement with balloon angioplasty. Read More

View Article and Full-Text PDF

Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement.

Clin Res Cardiol 2021 May 20;110(5):699-710. Epub 2021 Mar 20.

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany.

Background: In recent studies, a 5-stage cardiac damage classification in severe aortic stenosis (AS) based on echocardiographic parameters has shown to provide predictive value regarding clinical outcome. The objective of this study was to investigate the prognostic impact of a cardiac damage classification based on invasive hemodynamics in patients with AS undergoing transcatheter aortic valve replacement (TAVR).

Methods: A total of 1400 patients with symptomatic AS and full invasive hemodynamic assessment before TAVR were included. Read More

View Article and Full-Text PDF

Aortic Stenosis Progression, Cardiac Damage, and Survival: Comparison Between Bicuspid and Tricuspid Aortic Valves.

JACC Cardiovasc Imaging 2021 Mar 11. Epub 2021 Mar 11.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address:

Objectives: This study sought to compare aortic stenosis (AS) progression rates, AS-related cardiac damage (AS-CD) indicator incidence and determinants, and survival between patients with tricuspid aortic valve (TAV)-AS and those with bicuspid aortic valve (BAV)-AS.

Background: Differences in AS progression and AS-CD between patients with BAV and patients with TAV are unknown.

Methods: We retrospectively studied consecutive patients with baseline peak aortic valve velocity (peakV) ≥2. Read More

View Article and Full-Text PDF

Gerbode defect following surgical mitral valve replacement and tricuspid valve repair: a case report.

Eur Heart J Case Rep 2021 Feb 30;5(2):ytaa534. Epub 2020 Dec 30.

Division of Cardiovascular Medicine, Department of Internal Medicine, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH, 44106, USA.

Background: Gerbode defect is a congenital or acquired communication between the left ventricle and right atrium. While the defect is becoming a more well-recognized complication of cardiac surgery, it presents a diagnostic and therapeutic challenge for providers. This case highlights the predisposing factors and imaging features that may assist in the diagnosis of Gerbode defect, as well as potential approaches to treatment. Read More

View Article and Full-Text PDF
February 2021

Transcatheter Tricuspid Valve-in-Valve Implantation with a Novel Balloon Expandable Myval® THV.

Ann Thorac Surg 2021 Mar 15. Epub 2021 Mar 15.

Medicana International Ankara Hospital, Department of Cardiology.

The transcatheter tricuspid valve-in-valve implantation (TVIV) has not yet been clarified, and several case series have documented results in patients with tricuspid bioprosthetic valve degeneration who underwent transcatheter implantation of Edwards SAPIEN XT, SAPIEN 3 and Medtronic valves. Here, we present a patient with severe bioprosthetic tricuspid valve stenosis who was successfully treated with the transfemoral route through the 29-mm novel balloon expandable Myval THV system which is the first in the literature. Read More

View Article and Full-Text PDF

Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial.

Am Heart J 2021 Mar 10;237:25-33. Epub 2021 Mar 10.

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC; Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD.

Background: Previous studies from the Low Risk TAVR (LRT) trial demonstrated that transcatheter aortic valve replacement (TAVR) is safe and feasible in low-risk patients, with excellent 30-day and 1-year outcomes. The objective of this study was to report clinical outcomes and the impact of 30-day hypoattenuated leaflet thickening (HALT) on structural valve deterioration (SVD) 2 years after TAVR.

Methods: The LRT trial was the first Food and Drug Administration-approved Investigational Device Exemption trial in the United States to evaluate the safety and feasibility of TAVR in low-risk patients with symptomatic severe tricuspid aortic stenosis (AS). Read More

View Article and Full-Text PDF

[Evaluation of the safety and efficacy of transcatheter aortic valve replacement with domestic prostheses for patients with severely stenotic bicuspid aortic valve].

Zhonghua Xin Xue Guan Bing Za Zhi 2021 Mar 24;49(3):250-256. Epub 2021 Mar 24.

Department of Cardiology, First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China.

To evaluate the safety and efficacy of transcatheter aortic valve replacement (TAVR) with domestic prostheses in patients with severely stenotic bicuspid aortic valve (BAV). This study was a prospective single-center non-randomized controlled study. Patients with symptomatic severe aortic stenosis (AS), who underwent TAVR with domestic prostheses at the First Affiliated Hospital of Air Force Medical University from January 2016 to April 2020 were consecutively included in our study. Read More

View Article and Full-Text PDF

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.

Circulation 2021 Mar 8;143(10):1043-1061. Epub 2021 Mar 8.

Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases (F.V., T.D., C.D., N.D., B.V., B.S., T.P., H.S., G.S., E.VB.).

After 15 years of successive randomized, controlled trials, indications for transcatheter aortic valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could become the first line treatment for patients with a symptomatic severe aortic stenosis and a tricuspid aortic valve anatomy. However, randomized, controlled trials have excluded bicuspid aortic valve (BAV), which is the most frequent congenital heart disease occurring in 1% to 2% of the total population and representing at least 25% of patients 80 years of age or older referred for aortic valve replacement. Read More

View Article and Full-Text PDF

Prognostic implication of right ventricular dysfunction and tricuspid regurgitation following transcatheter aortic valve replacement.

Catheter Cardiovasc Interv 2021 Mar 7. Epub 2021 Mar 7.

Department of Cardiology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Objectives: Right ventricular (RV) dysfunction and tricuspid regurgitation (TR) are associated with adverse outcomes in severe aortic stenosis (AS) patients. Our aim was to evaluate the association between ≥moderate TR and RV dysfunction on long-term mortality following transcatheter aortic valve replacement (TAVR).

Methods: A retrospective analysis of the Israeli multicenter TAVR registry among 4,344 consecutive patients, with all-cause mortality as the main outcome measure. Read More

View Article and Full-Text PDF

Left ventricular reverse remodeling and function by strain analysis in aortic stenosis: A CMR analysis of the EPICHEART study.

Rev Port Cardiol 2021 Mar 3;40(3):153-164. Epub 2021 Mar 3.

Department of Surgery and Physiology, Cardiovascular Research Unit (UnIC), Faculty of Medicine, University of Porto, Portugal.

Introduction And Objectives: In severe aortic stenosis (AS), the impact of aortic valve replacement (AVR) on left ventricular (LV) systolic function assessed by strain and measured by echocardiography or cardiac magnetic resonance (CMR) has been controversial. We aimed to investigate LV systolic myocardial function changes six months after AVR using global longitudinal (GLS), circumferential (GCS) and radial (GRS) strain derived from CMR imaging.

Methods: We included 39 severe AS patients (69. Read More

View Article and Full-Text PDF